Finance

Lists
Why is VYGR down ७.३५%?
Dive Deeper
VYGR:NASDAQ
Voyager Therapeutics Inc
US$ २.२७
-७.३५%
(-०.१८) 1D
US$ २.२८
+०.४४% (+०.०१००)
After hours
Closed: अक्टोबर १२, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VYGR...
Open
US$ २.४६
High
US$ २.४७
Low
US$ २.२५
Mkt. cap
१३.९९ करोड
Avg. vol.
६.०४ लाख
Volume
९.६७ लाख
52-wk high
US$ ५.५५
52-wk low
US$ २.२५
EPS
-US$ १.८१
Beta
१.२९
Shares outstanding
६.१६ करोड
No. of employees
१४१
Open
US$ २.४६
High
US$ २.४७
Low
US$ २.२५
Mkt. cap
१३.९९ करोड
Avg. vol.
६.०४ लाख
Volume
९.६७ लाख
52-wk high
US$ ५.५५
52-wk low
US$ २.२५
EPS
-US$ १.८१
Beta
१.२९
Shares outstanding
६.१६ करोड
No. of employees
१४१
News stories
From web sources and news partners
About Voyager Therapeutics Inc
CEO-
Employees१४१
Founded२०१३
HeadquartersLexington, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websitevoyagertherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to VYGR in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for VYGR in the last 3 months.
Highest
Current US$ २.२७
US$ २५.०० (+१,००१.३२%)
Average
US$ १३.७५ (+५०५.७३%)
Lowest
US$ ८.०० (+२५२.४२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wells Fargo
Buy
Maintained
US$ १०.००
+३४०.५%
10/02/2026
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
US$ २५.००
+१,००१.३%
09/21/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
US$ १२.००
+४२८.६%
08/12/2026
Yun Zhong
Wedbush
Buy
Maintained
US$ ८.००
+२५२.४%
08/07/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/06/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
US$ २२.००
+८६९.२%
06/02/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
US$ १८.००
+६९३%
05/08/2026
Samantha Semenkow
Citi
Buy
Reiterated
US$ ११.००
+३८४.६%
03/23/2026
Joon Lee
Truist Financial
Buy
Maintained
-
-
03/17/2026
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
-US$ ०.४० / -US$ ०.५१
+२१.२२%beat
Revenue / Est. (USD)
३१.६५ लाख / ४५.६३ लाख
-३०.६४%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.३४ करोड
१.५३ करोड
२५.९३ लाख
३१.६५ लाख
Cost of goods sold
३.५९ करोड
३.३६ करोड
२.४६ करोड
२.२० करोड
Cost of revenue
३.५९ करोड
३.३६ करोड
२.४६ करोड
२.२० करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८०.९३ लाख
८२.१६ लाख
८२.६१ लाख
७५.१६ लाख
Operating expense
८०.९३ लाख
८२.१६ लाख
८२.६१ लाख
७५.१६ लाख
Total operating expenses
४.४० करोड
४.१८ करोड
३.२९ करोड
२.९६ करोड
Operating income
-३.०६ करोड
-२.६४ करोड
-३.०३ करोड
-२.६४ करोड
Other non operating income
४.०० लाख
४.०४ लाख
४.३५ लाख
४.११ लाख
EBT including unusual items
-२.७८ करोड
-२.७४ करोड
-२.७९ करोड
-२.४५ करोड
EBT excluding unusual items
-२.७८ करोड
-२.३९ करोड
-२.७९ करोड
-२.४५ करोड
Income tax expense
८३.०० हजार
९.०० हजार
१४.०० हजार
२०.०० हजार
Effective tax rate
-०.३०%
-०.०३%
-०.०५%
-०.०८%
Other operating expenses
-
-
-
-
Net income
-२.७९ करोड
-२.७४ करोड
-२.७९ करोड
-२.४५ करोड
Net profit margin
-२०८.६९%
-१७८.८३%
-१,०७७.४०%
-७७३.२४%
Earnings per share
-०.४७
-०.४७
-०.४७
-०.४०
Interest and investment income
२३.८५ लाख
२१.११ लाख
१९.१२ लाख
१५.२८ लाख
Interest expense
-
-
-
-
Net interest expenses
२३.८५ लाख
२१.११ लाख
१९.१२ लाख
१५.२८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.९७ करोड
-२.५४ करोड
-२.९३ करोड
-२.५५ करोड
Gain or loss from assets sale
-
६२.०० हजार
-
१.०५ लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू